Reduction in mean glomerular pore size coincides with the development of large shunt pores in patients with diabetic nephropathy

Experimental Nephrology

Volumn 9, Issue 1, 2001, Pages 49-53

  Oberbauer, Rainer ^a   Nenov, Vesselin ^c   Weidekamm, Claudia ^a   Haas, Martin ^a   Szekeres, Thomas ^b   Mayer, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ECONOMICS VARNA   (Bulgaria)

Author keywords

Albuminuria; Cystatin c; Dextran; Diabetes; Nephropathy; Permselectivity

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; DEXTRAN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CLEARANCE; MALE; MATHEMATICAL MODEL; MEAN ARTERIAL PRESSURE; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ALBUMINURIA; CYSTATINS; DEXTRANS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERMEABILITY;

EID: 0035229481     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Proteinuria as a consequence of altered glomerular permselectivity - Clinical implications
2. Macromolecule transport across glomerular capillaries: Application of pore theory
3. Influence of molecular configuration on the passage of molecules across the glomerular capillary wall
4. Determination of glomerular size-selectivity in the normal rat with Ficoll
5. The blood serum concentration of cystatin C (y-trace) as a measure of the glomerular filtration rate
6. Structure and expression of the human cystatin c gene
7. Serum cystatin c measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine
8. Renal handling of radiolabelled human cystatin c in the rat
9. Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population
10. Glomerular permselectivity in proteinuric patients after kidney transplantation
11. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy
12. Heteroporous model of glomerular size selectivity: Applications to normal and nephrotic humans
13. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans
14. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease